MCM
M28 Capital Management Portfolio holdings
AUM
$138M
1-Year Est. Return
98.15%
This Fund
S&P 500
1 Year Est. Return
+98.15%
AUM
$138M
AUM Growth
+$69.6M
(+102%)
Holding
9
Top Buys
No buys this quarter
Top Sells
No sells this quarter
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Wave Life Sciences
WVE
$2.53B
| $96.3M | 70% |
5,664,548
|
|
||
2
Invivyd
IVVD
$471M
| $22.8M | 16.6% |
9,248,250
|
|
||
3
TG Therapeutics
TGTX
$4.59B
| $4.82M | 3.5% |
161,600
|
|
||
4
Arrowhead Research
ARWR
$8.94B
| $4.47M | 3.25% |
67,400
|
|
||
5
Fractyl Health
GUTS
$76.4M
| $4.08M | 2.97% |
1,856,117
|
|
||
6
ProQR Therapeutics
PRQR
$167M
| $2.06M | 1.5% |
1,019,498
|
|
||
7
Rocket Pharmaceuticals
RCKT
$544M
| $1.35M | 0.98% |
385,680
|
|
||
|
SLN
8
Silence Therapeutics
SLN
$259M
| $1.13M | 0.82% |
185,100
|
|
||
9
Curis
CRIS
$14M
| $514K | 0.37% |
521,059
|
|